Leukaemia cutis with chronic myelomonocytic leukaemia
Renal infiltration associated with chronic myelomonocytic leukaemia
New insights into the haemostatic function of platelets
Transfusion-related acute lung injury (TRALI)
Common community acquired infections and subsequent risk of chronic lymphocytic leukaemia
A new polycythaemia vera-associated SOCS3 SH2 mutant (SOCS3F136L) cannot regulate erythropoietin responses
The anti-leukaemic activity of novel synthetic naphthoquinones against acute myeloid leukaemia
Bi-directional activation between mesenchymal stem cells and CLL B-cells
Evidence for a novel mechanism for gene amplification in multiple myeloma
Phospho-STAT5 and phospho-Akt expression in chronic myeloproliferative neoplasms
Phase II study of the histone deacetylase inhibitor MGCD0103 in patients with previously treated chronic lymphocytic leukaemia
Expression of histone deacetylases in lymphoma
Associated cancers in parents and offspring of polycythaemia vera and myelofibrosis patients
Impact of prior therapies on the relative efficacy of bortezomib compared with dexamethasone in patients with relapsed/refractory multiple myeloma
Prevalence of mutations in ELANE, GFI1, HAX1, SBDS, WAS and G6PC3 in patients with severe congenital neutropenia
High incidence of haemophagocytic syndrome following umbilical cord blood transplantation for adults
Absence of VOD in paediatric thalassaemic HSCT recipients using defibrotide prophylaxis and intravenous Busulphan
Timing of initiation of enzyme replacement therapy after diagnosis of type 1 Gaucher disease
Suppression of the hepcidin-encoding gene Hamp permits iron overload in mice lacking both hemojuvelin and matriptase-2/TMPRSS6
Rate of change of sickle allele frequency may be influenced by total fertility rate
Concurrent thrombotic thrombocytopenic purpura and antiphospholipid syndrome
Toll-like Receptors (TLRs) are expressed by myeloid leukaemia cell lines, but fail to trigger differentiation in response to the respective TLR ligands
Double de novo mutations of ELANE ( ELA2 ) in a patient with severe congenital neutropenia requiring high-dose G-CSF therapy